Nationwide Recall: Subpotent Levothyroxine Pills Prompt FDA Action
TL;DR Summary
The FDA issued a Class II recall for certain levothyroxine sodium tablets used to treat hypothyroidism after tests found subpotent levels of the active ingredient, potentially reducing effectiveness. Major Pharmaceuticals and Cardinal Health distributed twelve recalled dosages nationwide in cartons; the recall covered multiple lots, but the total quantity was not disclosed.
- FDA recalls levothyroxine sodium tablets. Here's what to know NBC 7 San Diego
- Thyroid medication described as 'subpotent drug' recalled by FDA WKYC
- Thyroid drug recall affects multiple dosage strengths across U.S. News4JAX
- Recall alert: Thyroid medication Levothyroxine recalled nationwide WSB-TV
- Thyroid medicine levothyroxine recalled nationwide: FDA NewsNation
Reading Insights
Total Reads
1
Unique Readers
6
Time Saved
3 min
vs 4 min read
Condensed
92%
615 → 52 words
Want the full story? Read the original article
Read on NBC 7 San Diego